サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363021

心臓カテーテル・心臓ガイドワイヤーの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2023年～2030年

Cardiac Catheters And Guidewires Market Size, Share & Trends Analysis Report By Product (Cardiac Catheters, Cardiac Guidewires), By End-use (Hospitals, Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心臓カテーテル・心臓ガイドワイヤーの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月14日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心臓カテーテル・心臓ガイドワイヤー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の心臓カテーテル・心臓ガイドワイヤー市場規模は、2023年から2030年にかけてCAGR 7.6％を記録し、2030年までに249億米ドルに達すると予測されています。

この業界は、老人人口の増加、市場における代替品の不足、世界の糖尿病罹患率の上昇、技術の進歩により成長すると予想されています。糖尿病患者は、高コレステロール、高血圧、心臓病、脳卒中などの特定の健康状態になりやすいです。さらに、長期にわたる糖尿病は、心臓の筋肉を直接コントロールする血管や神経にダメージを与えます。そのため、心血管疾患（CVD）を発症する可能性も高くなります。

さらに、糖尿病を患っている人は、若くして心臓病や脳卒中を発症する傾向もあります。さらに、糖尿病は肥満の引き金となり、CVDの素因を増加させる。糖尿病の罹患率の高さは、世界中でCVDの有病率が増加している主な原因の一つです。例えば、米国糖尿病協会によると、約3,730万人のアメリカ人が糖尿病を患っていると推定されており、これは全人口の約11.3％にあたる。さらに、国際糖尿病連合の第10版によると、世界中で5億3,700万人が糖尿病を患っており、2045年には7億人に達すると予測されています。さらに近年では、カリブ海地域、中東、ラテンアメリカ地域、太平洋諸島の一部の国々が、世界で最も糖尿病の有病率が高いという結果が出ています。

さらに、心臓カテーテル・心臓ガイドワイヤーデバイスの技術的進歩は、疾病リスクの高い患者を特定する際に臨床医をサポートすることができ、業界の成長に拍車をかけると予想されます。例えば、2022年2月、メドトロニックは、一般的な心臓リズム障害の治療のために、小児患者用の冷凍アブレーション心臓カテーテルのFDA拡大承認を受けました。したがって、このような製品の発売は成長機会となります。COVID-19パンデミックは、手術件数の減少により業界にマイナスの影響を与えました。しかし、規制が緩和されたため、各国は選択的手術を再開しており、予測期間中に業界が成長を続けることを示唆しています。

心臓カテーテル・心臓ガイドワイヤー市場レポート・ハイライト

  • 心臓カテーテル部門は、技術的に先進的な製品のイントロダクション、冠動脈インターベンション手技の増加、糖尿病罹患率の増加により、2022年に業界をリードしました。
  • 病院の最終用途セグメントは、慢性疾患の有病率の増加、老年人口の急増、カテーテルの技術進歩により、予測期間中に業界をリードすると予想されます。
  • アジア太平洋地域は予測期間中に最も速いCAGRを記録すると予想されています。認知度の向上、可処分所得の増加、慢性疾患の罹患率の上昇が、この地域の成長を後押しする主な要因です。
  • 国際的な企業が多数存在するため、業界の競合は激しいです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 心臓カテーテル・心臓ガイドワイヤーの市場変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 心臓カテーテル・心臓ガイドワイヤー市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 心臓カテーテル・心臓ガイドワイヤー：製品の推定・動向分析

  • 心臓カテーテル・心臓ガイドワイヤー市場：重要なポイント
  • 心臓カテーテル・心臓ガイドワイヤー市場：動向および市場シェア分析、2022年および2030年
  • 心臓カテーテル
    • 心臓カテーテル市場推計・予測、2018年～2030年
    • 電気生理学カテーテル
    • PTCAバルーンカテーテル
    • IVUSカテーテル
    • PTAバルーンカテーテル
    • ガイド延長カテーテル
    • その他
  • 心臓ガイドワイヤー
    • 心臓ガイドワイヤー市場推計・予測、2018年～2030年

第5章 心臓カテーテル・心臓ガイドワイヤー：最終用途の推定・動向分析

  • 心臓カテーテル・心臓ガイドワイヤー市場：重要なポイント
  • 心臓カテーテル・心臓ガイドワイヤー市場：動向および市場シェア分析、2022年および2030年
  • 病院
  • クリニック
  • 外来手術センター（ASC）

第6章 心臓カテーテル・心臓ガイドワイヤー市場：地域の推定・動向分析

  • 地域の見通し
  • 地域別の心臓カテーテル・心臓ガイドワイヤー市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Abbott
    • Boston Scientific Corporation
    • Getinge AB
    • Biosense Webster, Inc (Part of Johnson & Johnson)
    • MicroVention (Terumo Corporation)
    • BIOTRONIK SE & Co. KG
    • Medtronic
    • CORDIS (A, Cardinal Health Company)
    • QXMedical
    • Teleflex Incorporated
    • B. Braun
    • C. R., Bard, Inc
    • Cardinal Health
    • Merit Medical Systems
    • NIPRO
    • BrosMed Medical Co., Ltd.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America cardiac catheters & guidewires market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe cardiac catheters & guidewires market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 17 France cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 23 Sweden cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 25 Norway cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific cardiac catheters & guidewires market, by region, 2018 - 2030 (USD Million)
  • Table 31 China cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 32 China cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 34 Japan cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 36 India cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Australia cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Thailand cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America cardiac catheters & guidewires market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa cardiac catheters & guidewires market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait cardiac catheters & guidewires market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait cardiac catheters & guidewires market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cardiac catheters & guidewires: Market outlook
  • Fig. 9 Cardiac catheters & guidewires: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cardiac catheters & guidewires market driver impact
  • Fig. 15 Cardiac catheters & guidewires market restraint impact
  • Fig. 16 Cardiac catheters & guidewires market strategic initiatives analysis
  • Fig. 17 Cardiac catheters & guidewires market: Product movement analysis
  • Fig. 18 Cardiac catheters & guidewires market: Product outlook and key takeaways
  • Fig. 19 Cardiac catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Electrophysiology catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 PTCA balloon catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 IVUS catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 PTA balloon catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Guide extension catheter market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Cardiac guidewires market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Cardiac catheters & guidewires market: End-use movement analysis
  • Fig. 28 Cardiac catheters & guidewires market: End-use outlook and key takeaways
  • Fig. 29 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global cardiac catheters & guidewires market: Regional movement analysis
  • Fig. 33 Global cardiac catheters & guidewires market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68038-541-0

Cardiac Catheters And Guidewires Market Growth & Trends:

The global cardiac catheters and guidewires market size is anticipated to reach USD 24.9 billion by 2030, registering a CAGR of 7.6% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The industry is expected to grow due to the increasing geriatric population, lack of substitutes in the market, rising incidence of diabetes across the globe, and technological advancements. Diabetic patients are more prone to develop certain health conditions, such as high cholesterol, high blood pressure, heart diseases, and stroke. In addition, long-term diabetes damages the blood vessels and nerves that directly control the heart muscles. This also increases the chances of developing Cardiovascular Diseases (CVDs).

Moreover, people suffering from diabetes also tend to develop heart disease and stroke at a very young age. Furthermore, diabetes triggers the risk of developing obesity, which, in turn, increases the predisposition to CVDs. The high incidence of diabetes is one of the major reasons for the increased prevalence of CVDs across the globe. For instance, according to the American Diabetes Association, around 37.3 million Americans, which was around 11.3% of the total population, were estimated to be suffering from diabetes. Moreover, as per the 10th edition of the International Diabetes Federation, 537 million people worldwide have diabetes, which is anticipated to reach 700 million by 2045. Furthermore, in recent years, the Caribbean, Middle East, Latin America regions, and some nations of the Pacific Islands marked the highest prevalence of diabetes in the world.

Moreover, technological advancements in cardiac catheters & guidewires devices can support clinicians in identifying patients with a high risk of disease, which is anticipated to spur the industry growth. For instance, in February 2022, Medtronic received FDA expanded approval for cryoablation cardiac catheters for pediatric patients for the treatment of a common heart rhythm disorder. Hence, such product launches provide growth opportunities. The COVID-19 pandemic had a negative impact on the industry due to a decrease in surgical procedure volumes. However, due to the ease in restrictions, countries have resumed elective procedures, suggesting that the industry will keep growing during the projected period.

Cardiac Catheters And Guidewires Market Report Highlights:

  • The cardiac catheters segment led the industry in 2022 due to the introduction of technologically advanced products, rising number of coronary interventional procedures, and increasing incidence of diabetes
  • The hospital end-use segment is expected to lead the industry during the forecast years due to the increasing prevalence of chronic diseases, rapidly growing geriatric population, and technological advancements in catheters
  • Asia Pacific is expected to register the fastest CAGR over the forecast period. Growing awareness levels, increasing disposable income, and rising incidence of chronic conditions are the key factors boosting the region's growth
  • The industry is highly competitive due to the presence of many international companies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cardiac Catheters & Guidewires Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Cardiac Catheters & Guidewires Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Cardiac Catheters & Guidewires: Product Estimates & Trend Analysis

  • 4.1. Cardiac Catheters & Guidewires Market: Key Takeaways
  • 4.2. Cardiac Catheters & Guidewires Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cardiac Catheters
    • 4.3.1. Cardiac catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Electrophysiology catheters
      • 4.3.2.1. Electrophysiology catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. PTCA balloon catheters
      • 4.3.3.1. PTCA balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. IVUS catheters
      • 4.3.4.1. IVUS catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. PTA balloon catheters
      • 4.3.5.1. PTA balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Guide extension catheter
      • 4.3.6.1. Guide extension catheter market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Cardiac Guidewires
    • 4.4.1. Cardiac guidewires market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cardiac Catheters & Guidewires: End-use Estimates & Trend Analysis

  • 5.1. Cardiac Catheters & Guidewires Market: Key Takeaways
  • 5.2. Cardiac Catheters & Guidewires Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Clinics
    • 5.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers (ASCs)
    • 5.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cardiac Catheters & Guidewires Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Cardiac Catheters & Guidewires Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Boston Scientific Corporation
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Getinge AB
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Biosense Webster, Inc (Part of Johnson & Johnson)
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. MicroVention (Terumo Corporation)
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. BIOTRONIK SE & Co. KG
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Medtronic
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. CORDIS (A, Cardinal Health Company)
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. QXMedical
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Teleflex Incorporated
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. B. Braun
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. C. R., Bard, Inc
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Cardinal Health
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Merit Medical Systems
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. NIPRO
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. BrosMed Medical Co., Ltd.
      • 7.2.16.1. Company overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives